G. Watson

发表

The relationship between neuropsychological functioning and driving ability in dementia: a meta-analysis.

M. Reger, S. Craft, R. Welsh, 2004, Neuropsychology.

Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics.

T. Montine, J. Quinn, A. Espay, 2013, Journal of Parkinson's disease.

Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

S. Minoshima, D. Cross, S. Craft, 2011, Archives of neurology.

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial

T. Montine, S. Minoshima, D. Cross, 2011 .

Insulin and neurodegenerative disease: shared and specific mechanisms

Suzanne Craft, S. Craft, G. Watson, 2004, The Lancet Neurology.

APOE ε4 increases risk for dementia in pure synucleinopathies.

Daniel Weintraub, Oscar L Lopez, David A Bennett, 2013, JAMA neurology.

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.

Suzanne Craft, Emily H. Trittschuh, S. Plymate, 2013, Journal of Alzheimer's disease : JAD.

Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system.

S. Craft, G. Watson, C. Savard, 2009, Journal of Alzheimer's disease : JAD.

The Role of Insulin Resistance in the Pathogenesis of Alzheimer’s Disease

S. Craft, G. Watson, G. Watson, 2003, CNS drugs.

Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis

S. Craft, G. Watson, G. Watson, 2006, Journal of the Neurological Sciences.

Intranasal insulin improves cognition and modulates β-amyloid in early AD

P. Mehta, S. Plymate, S. Craft, 2008, Neurology.

O3-05-05 Therapeutic effects of daily intranasal insulin administration in early Alzheimer’s disease

M. Reger, S. Craft, J. Breitner, 2006, Alzheimer's & Dementia.

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.

S. Craft, G. Watson, G. Watson, 2004, European journal of pharmacology.

The Role of Insulin Resistance in Age-Related Cognitive Decline and Dementia

S. Craft, G. Watson, 2009 .

Aberrant Detergent-Insoluble Excitatory Amino Acid Transporter 2 Accumulates in Alzheimer Disease

T. Montine, J. Kaye, J. Quinn, 2010, Journal of neuropathology and experimental neurology.

Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.

T. Montine, S. Craft, N. Postupna, 2013, JAMA neurology.

Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.

G. Schellenberg, M. Reger, S. Plymate, 2008, Journal of Alzheimer's disease : JAD.

GLT-1 loss accelerates cognitive deficit onset in an Alzheimer's disease animal model.

G. Watson, Kohichi Tanaka, P. Green, 2011, Journal of Alzheimer's disease : JAD.

Statin users without an APOE-epsilon4 allele have increased insulin resistance.

M. Reger, S. Plymate, S. Craft, 2010, Journal of Alzheimer's disease : JAD.

Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease.

T. Montine, Jing Zhang, J. Leverenz, 2011, Parkinsonism & related disorders.

Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.

T. Montine, S. Plymate, S. Craft, 2011, Archives of neurology.

Neuropsychologic assessment in collaborative Parkinson’s disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson’s Disease Research at the University of Pennsylvania and the University of Washington

T. Montine, J. Trojanowski, A. Siderowf, 2013, Alzheimer's & Dementia.

Memory, mood, and vitamin D in persons with Parkinson's disease.

T. Montine, J. Quinn, J. Leverenz, 2013, Journal of Parkinson's disease.

Help-Seeking from Clergy and Spiritual Counselors Among Veterans with Depression and PTSD in Primary Care

D. G. Campbell, L. Rubenstein, E. Chaney, 2013, Journal of Religion and Health.

Evaluation of mild cognitive impairment subtypes in Parkinson's disease

T. Montine, J. Quinn, A. Espay, 2014, Movement disorders : official journal of the Movement Disorder Society.

Progress in Neurotherapeutics and Neuropsychopharmacology: Insulin Resistance Alzheimer's Disease: Pathophysiology and Treatment

S. Craft, G. Watson, G. Watson, 2008 .

Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion

G. Watson, J. Stanford, S. Fowler, 2010, Pharmacology Biochemistry and Behavior.

Intranasal insulin improves cognition and modulates β-amyloid in early AD

P. Mehta, S. Plymate, S. Craft, 2008, Neurology.

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

B. Gerton, G. Watson, P. Green, 2012, Archives of neurology.

Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.

T. Montine, N. Postupna, Jing Zhang, 2013, JAMA neurology.

Memory, mood, and vitamin D in persons with Parkinson's disease.

T. Montine, J. Leverenz, C. Zabetian, 2013, Journal of Parkinson's disease.

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance

Beate Ritz, Daniel Weintraub, James B Leverenz, 2014, Movement disorders : official journal of the Movement Disorder Society.